Belantamab (Anti-TNFRSF17 / BCMA / CD269)
Product Specifications
CAS Number
2061894-48-0
Synonyms
GSK2857914
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Belantamab (Anti-TNFRSF17 / BCMA / CD269) is a humanized monoclonal antibody directed against the B-cell maturation antigen (BCMA) that can be used in the synthesis of an antibody-drug conjugate (ADC), Belantamab mafodotin. MW : 145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC550017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF555 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472475-100 1x 100 µL
GLUT-1 (Tumor Progression and Mesothelioma Marker) (GLUT1/2475), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042062-500 1x 500 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2062), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941887-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/1887R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details